|
1.
|
WL SmithRM GaravitoDL DeWittProstaglandin
endoperoxide H synthases (cyclooxygenases)-1 and -2J Biol
Chem2713315733160199610.1074/jbc.271.52.331578969167
|
|
2.
|
RA GuptaRN DuboisColorectal cancer
prevention and treatment by inhibition of cyclooxygenase-2Nat Rev
Cancer11121200110.1038/3509401711900248
|
|
3.
|
RA SoslowAJ DannenbergD RushBM WoernerKN
KhanJ MasferrerAT KokiCOX-2 is expressed in human pulmonary,
colonic, and mammary
tumorsCancer8926372645200010.1002/1097-0142(20001215)89:12%3C2637::AID-CNCR17%3E3.0.CO;2-B11135226
|
|
4.
|
C DenkertM KobelS PestI KochS BergerM
SchwabeA SiegertA RelesB KlosterhalfenS HauptmannExpression of
cyclooxygenase 2 is an independent prognostic factor in human
ovarian carcinomaAm J
Pathol160893903200210.1016/S0002-9440(10)64912-711891188
|
|
5.
|
BM ErovicM WoegerbauerJ PammerE SelzerMCh
GraslD ThurnherStrong evidence for up-regulation of
cyclooxygenase-1 in head and neck cancerEur J Clin
Invest386166200810.1111/j.1365-2362.2007.01896.x18173552
|
|
6.
|
T DaikokuD WangS TranguchJD MorrowS
OrsulicRN DuboisSK DeyCyclooxygenase-1 is a potential target for
prevention and treatment of ovarian epithelial cancerCancer
Res6537353744200510.1158/0008-5472.CAN-04-381415867369
|
|
7.
|
G SteinbachPM LynchRK PhillipsMH WallaceE
HawkGB GordonN WakabayashiB SaundersY ShenT FujimuraLK SuB LevinThe
effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial
adenomatous polyposisN Engl J
Med34219461952200010.1056/NEJM20000629342260310874062
|
|
8.
|
BT RagelRL JensenDL GillespieSM PrescottWT
CouldwellCelecoxib inhibits meningioma tumor growth in a mouse
xenograft modelCancer109588597200710.1002/cncr.2244117177201
|
|
9.
|
M YaoS KargmanEC LamCR KellyY ZhengE
KwongJF EvansMM WolfeInhibition of cyclooxygenase-2 by rofecoxib
attenuates the growth and metastatic potential of colorectal
carcinoma in miceCancer Res63586592200312566300
|
|
10.
|
ME UrickJR GilesPA JohnsonVEGF expression
and the effect of NSAIDs on ascites cell proliferation in the hen
model of ovarian cancerGynecol
Oncol110418424200810.1016/j.ygyno.2008.05.01818606441
|
|
11.
|
NK AltorkiP ChristosJL PortPC LeeF MirzaC
SpinelliR KeresztesD BeneckS PaulBM StilesY ZhangDS
SchrumpPreoperative taxane-based chemotherapy and celecoxib for
carcinoma of the esophagus and gastroesophageal junction: results
of a phase 2 trialJ Thorac
Oncol611211127201110.1097/JTO.0b013e31821529a921532508
|
|
12.
|
M SenzakiS IshidaA YadaM HanaiK FujiwaraS
InoueT KimuraS KurakateCS-706, a novel cyclooxygenase-2 selective
inhibitor, prolonged the survival of tumor-bearing mice when
treated alone or in combination with anti-tumor chemotherapeutic
agentsInt J Cancer12213841390200810.1002/ijc.23250
|
|
13.
|
B XinY YokoyamaT ShigetoH
MizunumaAnti-tumor effect of non-steroidal anti-inflammatory drugs
on human ovarian cancersPathol Oncol
Res13365369200710.1007/BF0294031818158574
|
|
14.
|
J ReeseX ZhaoWG MaN BrownTJ MaziaszSK
DeyComparative analysis of pharmacologic and/or genetic disruption
of cyclooxygenase-1 and cyclooxygenase-2 function in female
reproduction in miceEndocrinology14231983206200111416042
|
|
15.
|
CS WilliamsAJ WatsonH ShengR HelouJ ShaoRN
DuboisCelecoxib prevents tumor growth in vivo without toxicity to
normal gut: lack of correlation between in vitro and in vivo
modelsCancer Res6060456051200011085526
|
|
16.
|
YW JungSW KimS KimJH KimNH ChoJW KimYT
KimPrevalence and clinical relevance of cyclooxygenase-1 and -2
expression in stage IIB cervical adenocarcinomaEur J Obstet Gynecol
Reprod Biol1486266201010.1016/j.ejogrb.2009.09.01119836124
|
|
17.
|
SA GlynnRL PrueittLA RidnourBJ BoersmaTM
DorseyDA WinkJE GoodmanHG YfantisDH LeeS AmbsCOX-2 activation is
associated with Akt phosphorylation and poor survival in
ER-negative, HER2-positive breast cancerBMC
Cancer10626201010.1186/1471-2407-10-62621078168
|
|
18.
|
TL ErkinheimoH LassusP FinneBP van ReesA
LeminenO YlikorkalaC HaglundR ButzowA RistimäkiElevated
cyclooxygenase-2 expression is associated with altered expression
of p53 and SMAD4, amplification of HER-2/neu, and poor outcome in
serous ovarian carcinomaClin Cancer
Res10538545200410.1158/1078-0432.CCR-0132-0314760075
|
|
19.
|
KU SorenmoMH GoldschmidtFS ShoferC
GoldkampJ FerraconeEvaluation of cyclooxygenase-1 and
cyclooxygenase-2 expression and the effect of cyclooxygenase
inhibitors in canine prostatic carcinomaVet Comp
Oncol21323200410.1111/j.1476-5810.2004.00035.x19379307
|
|
20.
|
W LiJ WangHR JiangXL XuJ ZhangML LiuLY
ZhaiCombined effects of cyclooxygenase-1 and cyclooxygenase-2
selective inhibitors on ovarian carcinoma in vivoInt J Mol
Sci12668681201110.3390/ijms1201066821340007
|
|
21.
|
T KitamuraM ItohT NodaM MatsuuraK
WakabayashiCombined effects of cyclooxygenase-1 and
cyclooxygenase-2 selective inhibitors on intestinal tumorigenesis
in adenomatous polyposis coli gene knockout miceInt J
Cancer109576580200410.1002/ijc.2001214991580
|
|
22.
|
W LiHR JiangXL XuJ WangJ ZhangML LiuLY
ZhaiCyclin D1 expression and the inhibitory effect of celecoxib on
ovarian tumor growth in vivoInt J Mol
Sci1139994013201010.3390/ijms1110399921152316
|
|
23.
|
M YaoW ZhouS SanghaA AlbertAJ ChangTC
LiuMM WolfeEffects of nonselective cyclooxygenase inhibition with
low-dose ibuprofen on tumor growth, angiogenesis, metastasis, and
survival in a mouse model of colorectal cancerClin Cancer
Res1116181628200510.1158/1078-0432.CCR-04-169615746067
|
|
24.
|
DB HalesY ZhugeJA LagmanK AnsenbergerC
MahonA BaruaJL LuborskyJM BahrCyclooxygenases expression and
distribution in the normal ovary and their role in ovarian cancer
in the domestic hen (Gallus
domesticus)Endocrine33235244200810.1007/s12020-008-9080-z18498063
|
|
25.
|
F SpinellaL RosanoV Di CastroMR NicotraPG
NataliA BagnatoInhibition of cyclooxygenase-1 and -2 expression by
targeting the endothelin a receptor in human ovarian carcinoma
cellsClin Cancer
Res1046704679200410.1158/1078-0432.CCR-04-031515269139
|
|
26.
|
H ShengJ ShaoJD MorrowRD BeauchampRN
DuBoisModulation of apoptosis and Bcl-2 expression by prostaglandin
E2 in human colon cancer cellsCancer Res5836236619989443418
|
|
27.
|
JL MasferrerKM LeahyAT KokiBS ZweifelSL
SettleBM WoernerDA EdwardsAG FlickingerRJ MooreK
SeibertAntiangiogenic and antitumor activities of cyclooxygenase-2
inhibitorsCancer Res6013061311200010728691
|
